Related Experiment Video
Updated: Feb 11, 2026

Protocol for Long Duration Whole Body Hyperthermia in Mice
Published on: August 25, 2012
A protocol to decrease postoperative chylous effusion duration in children
Melissa M Winder1, Aaron W Eckhauser2, Claudia Delgado-Corcoran3
11Department of Pediatric Critical Care,Primary Children's Hospital,Salt Lake City,UT,USA.
Insights
Implementing a new management protocol significantly reduced chest tube use for pediatric patients with postoperative chylothorax. This quality improvement initiative shortened treatment duration and improved patient outcomes.
Area of Science:
- Pediatric Cardiac Surgery
- Thoracic Surgery
- Quality Improvement Initiatives
Background:
- Postoperative chylothorax is a known complication following pediatric cardiac surgery.
- Variability in management can lead to prolonged treatment and increased resource utilization.
Purpose of the Study:
- To decrease the time to resolution of postoperative chylothorax in pediatric patients.
- To reduce the duration of chest tube utilization through a standardized management protocol.
Main Methods:
- A quality improvement project implemented a chylothorax management protocol in July 2015.
- Retrospective analysis compared pre-protocol (n=20) and post-protocol (n=22) cohorts of pediatric patients (0-17 years) undergoing cardiac surgery.
- Data included chest tube duration, feeding strategies, and need for further interventions.
Main Results:
- Total chest tube utilization decreased from 12 to 7 days (p=0.047).
- Maximum chest tube duration reduced from 44 to 13 days.
- Medium-chain triglyceride feed duration decreased from 42 to 31 days (p=0.01).
Conclusions:
- A chylothorax management protocol is feasible and effective in pediatric cardiac surgery.
- Protocol implementation significantly decreased chest tube utilization and practice variability.
- The protocol led to shorter treatment durations without impacting ventilation or length of stay.
Objective:
Our primary goal was to decrease time to resolution of postoperative chylothorax as demonstrated by total days of chest tube utilisation through development and implementation of a management protocol.
Methods:
A chylothorax management protocol was implemented as a quality improvement project at a tertiary-care paediatric hospital in July, 2015. Retrospective analysis was completed on patients aged 0-17 years diagnosed with chylothorax within 30 days of cardiac surgery in a pre-protocol cohort (February, 2014 to June, 2015, n=20) and a post-protocol cohort (July, 2015 to March, 2016, n=22).Measurements and resultsPatient characteristics were similar before and after protocol implementation. Duration of mechanical ventilation and cardiac ICU and hospital lengths of stay were unchanged between cohorts. Following protocol implementation, total duration of chest tube utilisation decreased from 12 to 7 days (p=0.047) with a decrease in maximum days of chest tube utilisation from 44 to 13 days. Duration of medium-chain triglyceride feeds decreased from 42 days to 31 days (p=0.01). In total, three patients in the post-protocol cohort underwent additional surgical procedures to treat chylothorax with subsequent resolution of chylothorax within 24 hours. There were no chest tube re-insertions or re-admissions related to chylothorax in either the pre- or post-protocol cohorts. Protocol compliance was 81%.
Conclusions:
Adoption of a chylothorax management protocol is feasible, and in our small cohort of patients implementation led to a significant decrease in the duration of chest tube utilisation, while eliminating practice variability among providers.
Related Concept Videos
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Decreasing Function
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Decreased Body Temperature
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...

